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Abstract: Sophorolipids are one of the best known microbial biosurfactants and are produced by
several yeast species. The best studied producer is Starmerella bombicola, a non-pathogenic yeast
associated in nature with bumblebees. Sophorolipids are built up of the rare disaccharide sophorose,
which is attached to a fatty acid through a glyosidic bound. Sophorolipids produced by S. bombicola
mainly contain oleic acid as the incorporated hydrophobic group. Other chain lengths can, to a certain
content, be incorporated by feeding the yeast with substrates of alternative chain lengths. However,
the efficiency for such substrates is low as compared to the preferred C18 chain length and defined by
the substrate specificity of the first enzymatic step in sophorolipid biosynthesis, i.e., the cytochrome
P450 enzyme CYP52M1. To increase product uniformity and diversity at the same time, a new strain
of S. bombicola was developed that produces sophorolipids with a palmitic acid acyl chain. This was
achieved by heterologous expression of the cytochrome P450 cyp1 gene of Ustilago maydis and feeding
with palmitic acid. Optimization of the production was done by protein and process engineering.
Keywords: sophorolipid; biosurfactant; Starmerella bombicola; cytochrome P450; chimeragenesis;
enzyme engineering; process engineering; fermentation; purification; NMR
1. Introduction
Starmerella bombicola is a yeast known for its efficient production of sophorolipids, a kind of
naturally produced glycolipid biosurfactants [1]. The first step in the sophorolipid biosynthesis
involves hydroxylation of a fatty acid by a cytochrome P450 [2]. Cytochrome P450 enzymes are
hemeproteins known for their capacity to use molecular oxygen to be incorporated in a wide variety
of substrates. In addition to oxygenation reactions, other less common substrates like nitration are also
catalyzed by these enzymes [3].
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In sophorolipid biosynthesis, oxygenation of the fatty acids is carried out by the CYP52M1 enzyme,
and it largely determines the length of the fatty acids incorporated into the sophorolipids. The enzyme
has a high specificity toward fatty acids like stearic acid (18 carbons, zero double bonds, C18:0) and
oleic acid (C18:1), and less toward shorter fatty acids like palmitic (C16:0) or myristic (C14:0) acid.
In combination with the specificity of the first uridine diphosphate (UDP) glucosyltransferase (UGTA1),
this results in mainly C18:0 and C18:1, some C18:2 and C16:0 fatty acids being incorporated [4].
Therefore, most production processes are conducted with vegetable oils rich in oleic acids, such as
rapeseed oil or high-oleic sunflower oil, or with longer fatty acids. Though the incorporation of
these longer fatty acids is very efficient, it is also a burden when molecular diversification is desired.
Although, it is feasible to incorporate shorter alkyl chains via chemical or biocatalytical methods,
in vivo production is still inefficient [5].
Growth trials with shorter fatty acids mainly resulted in long-chain sophorolipids and some
smaller amounts of medium-chained ones [6]. This is due to the elongation of the shorter fatty acids
by elongase enzymes of the endoplasmic reticulum. Shorter fatty acids can also be degraded in
the β-oxidation pathway and those building blocks will serve as a substrate for de novo synthesis
of fatty acids [7]. However, when using specialized substrates like alcohols or ketones, short- and
medium-chained sophorolipids can be obtained [6,8]. The main problems with this are the high cost of
these substrates and the relatively low amounts of novel sophorolipids being produced. Engineering of
S. bombicola by knocking-out the β-oxidation or enzymes involved in long-chain alcohol oxidation
already improves the production of these novel new-to-nature molecules using cheaper substrates,
but the traditional sophorolipids still remain a part of the mixture since de novo fatty-acid synthesis
still occurs with subsequent incorporation of these fatty acids into the sophorolipids [9,10].
To summarize, the major factors hindering a uniform and efficient production of new-to-nature
molecules are de novo sophorolipid synthesis enzymes with quite strict substrate specificity, resulting in
suboptimal production of these new types. To circumvent this problem, one may try to express
a heterologous P450 enzyme with the desired substrate specificities. The CYP1 enzyme from
Ustilago maydis takes part in cellobiose lipid synthesis via terminal hydroxylation of palmitic acid
(C16:0) [11]. Because the enzyme solely catalyzes terminal hydroxylation, issues associated with
the stereochemistry of the hydroxy group are circumvented as well. These features render CYP1 a
promising candidate for creating sophorolipids with an altered fatty acid chain in S. bombicola.
2. Materials and Methods
2.1. Strains, Plasmids, and Culture Conditions
Starmerella bombicola ATCC22214 was the wild-type strain used during the experiments.
The derived PT36 strain, a ura3 auxotrophic mutant, was used to engineer all the mutants described in
this research [12]. As a hydrophobic substrate, rapeseed oil was used at 37.5 g/L, or another suitable
hydrocarbon like ethyl palmitate, palmitic acid, myristic acid, ethyl myristate, lauric acid, or ethyl
myristate at concentrations of 5 g/L in shake-flask experiments unless otherwise stated. All the
substrates were acquired from Sigma-Aldrich (USA).
Bioreactor experiments were carried out using the Biostat®B 3-L vessels (Sartorius BBI-systems;
Germany) with 1.5-L working volume using Norprene®tubing (formulation A-60-G, Saint-Gobain).
At inoculation, 1 L of production medium described by Lang was inoculated with 200 mL of a late
exponential culture [13]. The medium had an initial pH of 5.8 and was allowed to drop spontaneously
to pH 3.5 and was kept at this pH using a 5 M NaOH solution. Due to the acidification of the culture
broth by the yeast itself, no acid must be added. The reaction vessel was kept at 30 ◦C and stirred at
600 rpm. Aeration was kept at 1 L/min and 2 mL of ethyl palmitate was added manually every day.
Daily sampling of glucose concentrations and optical density was performed as stated in the sampling
and analysis section. When the glucose concentration dropped below 30 g/L, a pre-calculated volume
from a 60% glucose stock solution was added to the fermenter to a final concentration of 100 g/L.
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Larger fermentations were carried out in a 30-L B bioreactor of Braun Biotech International C20-3
(Germany). Aeration and stirrer rates can be found in the results section. Ethyl palmitate was kept on
a heating plate with magnetic stirring at a temperature of 60 ◦C.
2.2. Molecular Techniques
2.2.1. General Techniques
High-fidelity PCRs were performed with PrimeSTAR HS DNA Polymerase (Takara, Westburg,
Leusden, The Netherlands) when fragments were shorter than 3000 base pairs. Longer fragments were
amplified with PrimeSTAR GXL DNA Polymerase (Takara, Westburg, Leusden, The Netherlands).
For colony PCR, TAQ-polymerase (New England Biolabs) was used. Genomic DNA was isolated
using the Sigma Genomic DNA isolation kit (Sigma-Aldrich, Diegem, Belgium).
Primers, plasmids, and final strains were designed using the Clone Manager Basic Version
9 software suite from Sci-ED Software. Primers were ordered at Integrated DNA Technologies
(IDT, Leuven, Belgium) and diluted upon arrival to a 10 mM stock solution. Working solutions
were derived from these by a 100× dilution to 10 µmol. Sequencing of plasmids and intermediate
constructs was performed by LGC Genomics (Berlin, Germany). Used primers are listed in Table 1.
Table 1. Primers used during the research for the creation of the different Starmerella bombicola strains.
Primer Name Primer Sequence
P52 ATATGTACTTTTCAATATGATAAACGGAGAAATAACG
P69 GTTTCTTAGCCTCCCATGGAAG
P395 TGAAAAGTACATATGGTACCATGTCGCTCAAAGTGCAG
P396 AACGCTAGCTTGGCGTTATCTAGTGCCTTCCTTGCAAC
P722 AAAATTCCGCTTGGCGGTATTCCTTCACC
P723 GGGAGGCTAAGAAACTTACCCAGCCCACACGTCT
P788 GCCAAGCGGAATTTTTCTAGTGCCTTCCTTGCAACATCGAAGGG
P847 CGTTGTCAAGTCCTAAGGTAT
P887 AAGCGTGAAGCTCCTCTGACAATC
P1439 GTTTTCTGCCTTTTTGCGTAC
P1641 CGGAGACGGAAGCCAAATGGCACCTGCCGTTGAAGCAACG
P1642 CAAATACGGAGTAGCGAACGCCTTTTACTTCATCAGCA
P1643 CGTTGCTTCAACGGCAGGTGCCATTTGGCTTCCGTCTCCG
P1644 TGCTGATGAAGTAAAAGGCGTTCGCTACTCCGTATTTG
P1645 GCAAAACGTTTAACAATGCTTGAACTGCTTGAAAAATACC
P1646 CCGGGTATTTTTCAAGCAGTTCAAGCATTGTTAAACGTTTTGCC
Transformation of S. bombicola was done following the protocol of Saerens et al. [14]. Used and
made strains are listed in Table 2.
Table 2. Strains used and created during the research. NADPH—reduced nicotinamide adenine
dinucleotide phosphate; FMN—flavin mononucleotide.
Strain Characteristics
S. bombicola ∆cyp52m1 Knock-out strain of cyp52m1 [2]
S. bombicola cyp1 Knock-in of cyp1 at the cyp52m1 locus
S. bombicola cyp1-bmr Knock-in of cyp1bmr at the cyp52m1 locus
S. bombicola cyp1-nadph Knock-in of cyp1bmr with a mutation in the NADPH binding domain at the cyp52m1 locus
S. bombicola cyp1-fmn Knock-in of cyp1bmr with a mutation in the FMN domain at the cyp52m1 locus
S. bombicola cyp1-double Knock-in of cyp1bmr with a mutation in both the NADPH binding domain and the FMNdomain at the cyp52m1 locus
2.2.2. Vector Construction
All the plasmids and derived expression cassettes constructed in this research were targeted
toward the cyp52m1 locus (Figure S1). The P450 of interest was ligated between the cyp52m1 promoter
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and terminator. Selection was performed with the ura3 marker which is situated downstream of the
P450 coding sequence. Targeting of the expression cassette was performed using homologous regions
at the 5′ and 3′ sides of the linear cassette, which had a length of 1000 bp.
2.2.3. Heterologous Expression of Wild-Type Ustilago Maydis CYP1
The wild-type coding sequence of cyp1 from U. maydis 521 was ordered from GeneArt
(Figure S2) [11]. No codon optimization was performed, since the codon usage was similar to the
codon usage of S. bombicola. The sequence was amplified with primers P395 and P396 (2041 bp).
Primers P52 and P69 were used to amplify the cyp52m1 locus (7514 bp). Ligation was performed by the
In-Fusion HD Cloning kit. Transformation of Escherichia coli was performed as described by Sambrook
and Russel [15]. This resulted in plasmid BS_EC_0058. After sequencing, the expression cassette was
amplified from the plasmid with primers P847 and P947 (6512 bp). After transformation in S. bombicola
PT36 and selection on synthetic defined (SD) medium, the transformants were screened for correct
integration of the cassette by yeast colony PCR using primers P954 and P679 for the 5′ region and P953
and P95 for the 3′ region. The 5′ region fragment had a length of 1116 bp, and the 3′ region fragment
had a length of 1172 bp.
2.2.4. CYP1 Chimeric Construct
The earlier constructed plasmid BS_EC_0058 was used as a vector backbone to insert the Bacillus
megaterium CYP102A1 reductase domain. The vector backbone was amplified with primers P788 and
P69 (8558 bp). The reductase of B. megaterium ATCC14581 was amplified from genomic material with
primers P722 and P723 (1794 bp) and ligated using the In-Fusion HD Cloning Kit (Takara, Westburg,
Leusden, The Netherlands). This resulted in plasmid BS_EC_0091. The expression cassette was
amplified with primers P847 and P887 (7310 bp).
2.2.5. Validation of CYP1BMR Chimeric Construct
Validation of the function of the reductase domain of B. megaterium ATCC14581 was done by
introducing several mutations into the domains of the reductase. Part of the reductase was ordered
as a gBlock from IDT (Leuven, Belgium) (Figure S3). For the mutation in the flavin mononucleotide
(FMN) domain, primers P1645 and P1642 were used for the vector backbone (9657 bp) with plasmid
BS_EC_0091 as a template. The mutated sequence was amplified from the gBlock with primers P1644
and P1646 (761 bp). A similar strategy was followed for the mutation in the reduced nicotinamide
adenosine dinucleotide phosphate (NADPH)-binding domain with primers P1642 and P1645 for
the vector backbone with BS_EC_0091 (9766 bp) as a template and primers P1643 and P1645 for the
mutated sequence (645 bp). Finally, the double-mutation construct was created with primers P1641 and
P1642 for linearization of the vector BS_EC_0091 (9043 bp) and primer pair P1643 and P1644 for the
sequence carrying the double mutation (1372 bp). All vectors were assembled by Gibson assembly [16].
2.3. Sampling and Analysis
2.3.1. Follow-Up of Growth and Glucose Consumption
Biomass formation was followed by measuring the optical density at 600 nm using the FLUOstar
OPTIMA fluorometer (BMG LABTECH GmbH, Ortenberg, Germany). Samples were diluted in 0.9%
NaCl in distilled H2O solution if necessary. Follow-up of the glucose concentration was done with the
2700 Select Biochemistry Analyzer (YSI Inc., Yellow Springs, OH, USA). Samples were diluted in a
range between 0.1 and 7.5 g/L to ensure measurements within the linear range of the equipment.
2.3.2. Analysis of Sophorolipid Production
Sophorolipid production from shake-flask experiments was followed by sampling every two
days. Three volumes of ethanol were added to the culture broth samples. After shaking vigorously,
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the samples were spun down at 14,000× g for 5 min. The supernatant was analyzed using HPLC in
conjunction with an evaporative light scattering detector (ELSD) and LC–MS [6,14].
Recuperation of the sophorolipids from the fermentation broth was done using one of two
techniques depending on the used strain. Isolation from productive strains was done by placing
the culture broth overnight at 60 ◦C. This results in a precipitation of the sophorolipids produced.
Recovery of sophorolipids from low-producing strains was done via extraction with ethyl acetate.
Thin-layer chromatography (TLC) was performed to evaluate the purity of the sophorolipid
mixture after alkaline hydrolysis on Silica gel 60 F254 TLC plates (VWR). Sophorolipids were separated
using a chloroform/methanol/water eluent (65:15:2 v/v/v) and visualized by heating after dipping in
10% (v/v) H2SO4 [17].
2.3.3. Purification of C16:0 Sophorolipids from Culture Broth
Total extraction and subsequent purification of sophorolipids from the culture broth was
performed by adding ethyl acetate to the broth and collecting the ethyl acetate fraction after phase
separation. The ethyl acetate was evaporated and the extracted sophorolipids were dissolved in
distilled water. Consequently, a hexane washing step was performed to remove remaining oil and
fatty acids. The remaining water fraction was extracted again with ethyl acetate. The hexane washing
step and ethyl acetate extraction were repeated until no unwanted molecules were present in the
sophorolipid mixture. The sophorolipids were dissolved in distilled water and lyophilized until dry.
Alkaline hydrolysis (pH 12, 50% (w/w) NaOH, 100 ◦C, 1.5 h) was performed under reflux on the
purified sophorolipid mixture dissolved in distilled water to reduce the complexity by removing the
acetylations and lactonizations. Afterward, the pH was adjusted to 4 (5 M HCl) and the sophorolipids
were extracted using one volume of methyl tert-butyl ether (TBME). The TBME was evaporated and
the extracted sophorolipids were dissolved in distilled water. The obtained hydrolyzed product was
lyophilized again until dry. To check the purity of the sophorolipid mixture, both TLC and LC–MS
were performed.
2.3.4. NMR Analysis
1H and 13C NMR spectra were analyzed at 400 and 100.6 MHz with a Bruker Avance III device
(Bruker Biospin GmbH, Rheinstetten, Germany) using an 1H/BB z-gradient probe (BBO, 5 mm). Firstly,
20 mg of the purified product was dissolved in dimethyl sulfoxide-d6 (DMSO-d6), which was also
used as an internal chemical shift standard (2.50 ppm for 1H and 39.52 ppm for 13C). The spectra
(13C, COSY, and HSQC) were acquired through the standard sequences available in the Bruker pulse
program library and processed using the TOPSPIN 3.2. APT software. Custom settings were used for
HMBC (32 scans), TOCSY (100 ms MLEV spinlock, 0.1 s mixing time, 1.27 s relaxation delay, 16 scans)
and H2BC (21.8 ms mixing time, 1.5 s relaxation delay, 16 scans), according to literature [18,19].
3. Results
3.1. Expression of Wild-Type CYP1 from U. maydis in S. bombicola
The native cyp52m1 gene of S. bombicola was replaced by the cyp1 gene of U. maydis in S. bombicola
as described in the Materials and Methods section. To investigate the activity of CYP1 in S. bombicola,
an initial growth trial was performed on palmitic acid (5 g/L). A strain not capable of synthesizing
sophorolipids (a cyp52m1 knock-out, see Table 2) was used as the control. The LC–MS spectrum of
samples for the new strain in contrast to the control showed a signal for sophorolipids with molecular
mass 679 m/z (di-acetylated acidic sophorolipids with a C16:0 fatty acid chain; Figure 1). Its formic acid
adduct can also be seen (723 m/z). This shows that replacement of CYP52M1 by another P450 results in
sophorolipid production, with a different alkyl chain in comparison to the wild type. It has to be noted
that the amount of produced sophorolipids was very low. After eight days of production, the signal
was barely above the detection limit of the LC–MS.
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Fi re 1. Ma s spectrum scan at 24.5 min shows a signal of 16 carbons, zer dou le bonds (C16:0)
di-acetylated acidic sophorolipids (679 m/z).
3.2. Production Analysis of the CYP1 Chimeric P450
Although proof of concept was, thus, delivered, the production efficiency was very low. This can
be due to several effects, e.g., non-efficient electron transfer. CYP1 is a class II P450 requiring
assistance of a cytochrome P450 reductase (CPR) for delivery of electrons. Incompatibility of the
CPR can result in low or no electron transfer. Coupling a reductase to the P450 can help achieve
electron transfer. Therefore, introduction of a chimeric CYP1 (called CYP1BMR) in S. bombicola
was performed. The reductase domain was taken from CYP102A1 from Bacillus megaterium along
with the original CYP102A1 linker. The sophorolipid production was investigated on palmitic acid
(Figure 2), and indeed, increased amounts of C16:0 sophorolipids were detected for the strain with the
CYP1BMR construct compared to the first designed CYP1 strain, but still much lower than regular
wild-type sophorolipid production. LC–MS analysis revealed that other congeners were present as
well, mostly non- and mono-acetylated variants of the C16:0 sophorolipids.
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3.3. Validation of the CPR_BMR Functionality
In order to confirm that the introduction of the CPR was indeed responsible for the increased
productivities, several mutants were generated (Table 2). Mutating the flavin adenine dinucleotide
(FAD)/FMN-containing cytochrome P450 reductase (BMR) domain at essential residues would render
it less efficient in transporting the electrons to the P450, which should result in lower production levels,
proving that the BMR domain is responsible for electron donation. Essential residues in the FMN
domain are the glycine at position 570, the tryptophan at 574, and the tyrosine at 536 in CYP102A1 [20].
Similar to the FMN domain, several residues exist in the NADPH-binding domain that have an effect
on electron transfer and NADPH/NADP+ binding and stability [21,22]. There, a five-fold decrease in
the reduction of cytochrome c was measured with the C999A mutant. Both single mutants for both
domains, as well as a double mutant, were constructed and evaluated. The growth trial was conducted
using 5 g/L ethyl palmitate as a substrate with both single mutants, the double mutant, and the
non-mutated CYP1BMR strain. Sophorolipid production is represented in Figure 3. As can be seen,
the mutation in the NADPH domain did not result in a drop in sophorolipid production. The mutation
Colloids Interfaces 2018, 2, 42 7 of 13
in the FMN domain resulted in a five-fold drop, while the double mutant had a 16-fold reduction
compared to the non-mutated chimeric CYP1BMR. Though it was expected that both single mutations
would result in a reduction of production, the results show that this is not the case. Sequence analysis
performed after the production trial showed no reversion of the coding sequence of the NADPH mutant
(Figure S4). Overall, these data, combined with the enhanced productivity of CYP1BMR compared
with the wild-type non-chimeric P450, show that the BMR domain of CYP102A1 is responsible for the
donation of electrons to the CYP1 P450 enzyme.
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comparison between palmitic acid and ethyl palmitate was conducted and it was found that ethyl 
palmitate further enhanced productivity at least 50-fold (Figure 4). It has to be noted that the elution 
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Figure 3. C16:0 sophorolipid production by strains harboring the non-mutated chimeric protein
CYP1BMR and mutations in the reduced nicotinamide adenine dinucleotide phosphate (NADPH)
binding motif, flavin mononucleotide (FMN) domain, and both domains of the flavin adenine
dinucleotide (FAD)/FMN-containing cytochrome P450 reductase (BMR). Error bars represent the
standard deviation (SD; n = 3).
3.4. Substrate and Fermentation Optimization of CYP1BMR
Further optimization of the process was carried out by testing different substrates such as
fatty-acid ethyl esters. Substrate accessibility can be a bottleneck during production for some fatty
acids as they have high melting temperatures (e.g., palmitic acid: 63 ◦C) and are, thus, solid at 30 ◦C
(the cultivation temperature). Adding an emulsifier like Tween-20 can improve accessibility, but poses
different problems during downstream processing. Ethyl esters of fatty acids are liquid at room
temperature and were used in the past for efficient production of sophorolipids [23]. Therefore,
a comparison between palmitic acid and ethyl palmitate was conducted and it was found that
ethyl palmitate further enhanced productivity at least 50-fold (Figure 4). It has to be noted that
the elution times differ from the ones elsewhere due to a shortened HPLC-ELSD analysis protocol
to decrease the analysis time. After 11 days in the stationary phase, a final concentration of 1.56 g/L
was measured. The higher productivity can be explained by the fact that ethyl palmitate is liquid at
30 ◦C, while palmitic acid is not. The ethyl ester will easily disperse in the broth to form small droplets
ensuring a high contact surface. This will result in higher substrate availability for the yeast and enable
elevated sophorolipid production. The use of ethyl palmitate did not affect cell viability. During the
optimization, several substrate concentrations were used between 5 and 25 g/L. Increasing the amount
of ethyl ester did not further improve production of C16:0 sophorolipids. From the colony-forming
units, it became clear that higher amounts of ethyl esters up to 25 g/L did not cause a toxic effect which
might impair productivity (Figure S5). Therefore, in future shake-flask experiments, a concentration of
5 g/L was used. The use of shorter ethyl esters such as ethyl myristate did not result in the production
of different sophorolipids than the C16:0 ones.
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Figure 4. o parison of the production of 16:0 sophorolipids on pal itic acid ( ) versus ethyl
pal itate (B). The acidic di-acetylated C16:0 sophorolipids eluted at 15.5 min (679 m/z), and the
lactonic di-acetylated C16:0 sophorolipids at 15.8 in (661 m/z). The substrate ethyl pal itate eluted
at 25.1 in (283 m/z) while pal itic acid eluted at 27.5 in (255 m/z). It has to be noted that these
elution times differ from the ones used elsewhere in this manuscript due to the usage of a shortened
HPLC-ELSD analysis protocol.
3.5. Scale-Up of the CYP1BMR Chimeric Strain
Scale-up of production of C16:0 sophorolipids was first done in a 3-L and later in a 30-L bioreactor.
During this fermentation, heavy foaming occurred, which was problematic. It was observed that this
foaming was reduced each time ethyl palmitate was added to the fermenter. Therefore, the addition of
hydrophobic substrate was split up into two daily portions of 1 mL. In Figure 5, glucose consumption
and average optical density are depicted.
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Figure 5. Glucose consu ption and optical density for the 3-L fer entation ith Starmerella bombicola
CYP1B R using ethyl pal itate.
Depending on the growth phase, glucose consumption rates of 0.5 g/L·h and 0.4 g/L·h were
calculated for the exponential and stationary phases, respectively. The entire fermentation lasted
411.4 h with a total titer of 9.9 ± 0.1 (SD; n = 3) g/L of C16:0 sophorolipids. This correspon s to a
productivity of 24 ± 0.2 (SD; n = 3) mg/ ·h. Analysis by HPLC and LC–MS showed that the major
products being produced were the lactonic di-acetylated C16:0 sophorolipids (Figure 6).
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Figure 6. Sophor lipids produced in a 3-L fermenter using ethyl palmitate. At 18.9 min, non-acetylated
acidic C16:0 sophorolipids eluted (295 m/z). Di-acetylated ongeners wer present around 22.4 and
26.6 min, corresponding to acidic an l ctoni sophorolipids, resp ctively (679 and 661 m/ ).
Pal itic acid eluted at 37.4 (255 m/z).
Foam formation became even more troublesome on a 30-L scale compared to the 3-L scale. A first
30-L fermentation (fermentation A) was run using the same feeding and stirring strategy as the 3-L
fermenter. However, due to the excessive foam formation, aeration had to be reduced to approximately
0.1 vvm.
A second 30-L fermentation (fermentation B) used a different feeding strategy. Conventional
antifoam methods, such as the use of a silicon-based antifoam, were not desired due to separation
problems during downstream processing of these molecules from the sophorolipids. Because, when a
small amount of ethyl palmitate was added to the reactor, foam disappeared for 1 h after which it then
slowly started to accumulate again, the substrate was used as an antifoam by adding it every 20 min in
short bursts of 2 s (equaling 200 µL of ethyl palmitate). This way, it gave rise to a relatively foam-free
fermentation process. This allowed an overall higher aeration rate in fermentation B compared to A.
The parameters can be found in Table 3. As can be seen, due to the new feeding and antifoam strategy,
aeration could be increased up to 0.3 vvm in fermentation B.
Table 3. Parameters for 30-L fermentations A and B. The average optical density was calculated for the
stationary phase.
Fermentation A (Manual Feed) Fermentation B (Automatic Feed)
Aeration ±1.2 L/min (approx. 0.1 vvm) ±5 L/min (approx. 0.3 vvm)
Stirring rate 6 0 rpm 600 rpm
Total glucose consumption 3492 g 2577 g
Total ethyl palmitate 54.85 g 162 g
Duration 448 h 359 h
Average optical density 131.9 ± 16.7 120.9 ± 13.6
Sophorolipid titers 9.0 ± 0.2 g 12.1 ± 0.2 g
Productivity 20 ± 0.4 mg/L·h 33 ± 0.5 mg/L·h
t the e f t - fer e t ti s, t e r t as harvested and stored at 4 ◦C. After 48 h,
a brown precipitation could be observed. HPLC analysis reveale t t t ese ere : s r li i s.
hen comparing the two fermentations, the ratio of acidic versus lactonic C16:0 sophorolipids differe
(Figure 7). Fermentation A showed a lower amount of l ctonic sophorolipids compared to fer entation
B. In literature, aeration was described to affect the saturation degree of the fatty acids incorpor te
a d the lactonization degree of the produced sophorolipids [24–27].
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Figure 7. Difference in the ratio of the sophorolipid products in the two 30-L fermentations:
acidic (22.4 min, 679 m/z) and lactonic (26.6 min, 661 m/z) di-acetylated C16:0 sophorolipids.
3.6. NMR Structure Elucidation
Final confirmation of the molecular structure of the produced sophorolipids was done by
performing nuclear magnetic resonance spectroscopy (NMR) on the hydrolyzed C16:0 sophorolipids
obtained by stepwise purification and alkalin hydr lysis (see Section 2.3.3). This way, a uniform
product was obtained with only non-acetylated acidic C16:0 sophorolipids.
The chemical formula C28H52O13 was confirmed by the integrati n of the 1H and 13C NMR
spectra (Figure S6). When both subterminal a d terminal hydroxylation occur, a doublet around
1.12 ppm is detected in the 1H spectrum [28]. Considering that there is no signal that accounts for the
presence of a methyl group, here, only terminal hydroxylation occurred. NMR spectral analysis could
also validate the presence of two carbohydrates (two n meri protons) and a terminal c rboxyl group
(174.66 ppm in the 13C spectrum). The NMR data support the LC–MS identification, and onfirm the
molecular structure of the “novel” sophorolipids with a terminally bound palmitic cid tail, as shown
in Figur 8.
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4. Discussion
Introd cing a novel cytochrome P450 in S. bombicola to alter the fatty-acid tail of the produced
molecules is a valuable tool for creating tailor-made glycolipids. In this research, a shift toward
shorter chains of 16 carbon atoms was attained. In the case of CYP1 from U. maydis, a low amount
of activity (i.e., sophorolipid production) was obtained by heterologous expression of the wild-type
CYP1 U. maydis enzyme. To increase production, a strategy to ensure sufficient electron transfer from
the CPR to the P450 was evaluated via the generation of a chimeric P450 CYP1 from U. maydis with
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the BMR reductase domain of CYP102A1 from B. megaterium. Higher activity was detected for the
strain containing the fusion protein, which was confirmed to be caused by the attached BMR domain.
Interestingly, for the mutated NADPH-binding domain of BMR, a reduction was only observed when
it was combined with a mutation in the FMN domain. Though the exact reason remains unknown,
two mutations in the reductase domain might inflict substantial conformational changes, severely
impairing its function. Further optimization of the production strain and scale-up of the production
process resulted in more efficient production of C16:0 sophorolipids and the generation of 30 g of
C16:0 terminal hydroxylated sophorolipids. The product is currently being used for characterization
studies and application research. The overall productivity is still at least 40-fold lower than several
other reported strains [28,29], which shows that additional engineering and optimization is required.
Supplementary Materials: The following are available online at http://www.mdpi.com/2504-5377/2/4/42/s1:
Figure S1: Overview of the knock-in strategy at the cyp52m1 locus; Figure S2: Ordered coding sequence of
the Ustilago maydis cyp1 gene; Figure S3: Ordered mutated Bacillus megaterium cyp102a1 reductase sequence
(BMR); Figure S4: Sequencing of the BMR mutant strains; Figure S5: Effect of concentration of ethyl palmitate on
colony-forming units; Figure S6: 1H and 13C NMR spectra of C16:0 terminal hydroxylated sophorolipids.
Author Contributions: This manuscript was generated with an equal contribution from the first and second
authors (R.G. and M.D.G.). Conceptualization, R.G., I.N.A.V.B., and W.K.G.S. Methodology, R.G., M.D.G., J.V.M.,
C.L., M.D.S., and S.M. Validation, R.G., M.D.G., S.L., I.N.A.V.B., S.L.D.M., and S.L.K.W.R. Formal analysis, R.G.,
M.D.G., J.V.M., C.L., M.D.S., and S.M. Investigation, R.G., M.D.G., J.V.M., C.L., M.D.S., and S.M. Resources,
C.S. and W.K.G.S. Writing—original draft preparation, R.G., M.D.G., and S.L. Writing—review and editing,
M.D.G., S.L., S.L.D.M., S.L.K.W.R., and W.K.G.S. Visualization, R.G. and M.D.G. Supervision, I.N.A.V.B., S.L.D.M.,
and S.L.K.W.R.
Funding: This research was funded by the Flemish Agency Flanders Innovation and Entrepreneurship
(formerly known as the Agency for Innovation by Science and Technology; Grant No. 121129), the European
FP7 project Biosurfing (Grant No. 289219), and the Bio Based Industries Joint Undertaking under the European
Union’s Horizon 2020 research and innovation program (Grant No. 669003).
Conflicts of Interest: The authors declare no conflicts of interest.
References
1. Davila, A.-M.M.; Marchal, R.; Vandecasteele, J.-P.P. Sophorose lipid fermentation with differentiated substrate
supply for growth and production phases. Appl. Microbiol. Biotechnol. 1997, 47, 496–501. [CrossRef]
2. Van Bogaert, I.N.A.; Holvoet, K.; Roelants, S.L.K.W.; Li, B.; Lin, Y.-C.C.; Van de Peer, Y.; Soetaert, W.
The biosynthetic gene cluster for sophorolipids: A biotechnological interesting biosurfactant produced by
Starmerella bombicola. Mol. Microbiol. 2013, 88, 501–509. [CrossRef] [PubMed]
3. Barry, S.M.; Kers, J.A.; Johnson, E.G.; Song, L.; Aston, P.R.; Patel, B.; Krasnoff, S.B.; Crane, B.R.; Gibson, D.M.;
Loria, R.; et al. Cytochrome P450–catalyzed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis.
Nat. Chem. Biol. 2012, 8, 814–816. [CrossRef] [PubMed]
4. Saerens, K.M.J.; Van Bogaert, I.N.A.; Soetaert, W. Characterization of sophorolipid biosynthetic enzymes
from Starmerella bombicola. FEMS Yeast Res. 2015, 15, 1–9. [CrossRef] [PubMed]
5. Delbeke, E.I.P.; Movsisyan, M.; Van Geem, K.M.; Stevens, C.V. Chemical and enzymatic modification of
sophorolipids. Green Chem. 2016, 18, 76–104. [CrossRef]
6. Van Bogaert, I.; Fleurackers, S.; Van Kerrebroeck, S.; Develter, D.; Soetaert, W. Production of new-to-nature
sophorolipids by cultivating the yeast Candida bombicola on unconventional hydrophobic substrates.
Biotechnol. Bioeng. 2011, 108, 734–741. [CrossRef] [PubMed]
7. Tehlivets, O.; Scheuringer, K.; Kohlwein, S.D. Fatty acid synthesis and elongation in yeast. Biochim. Biophys.
Acta–Mol. Cell Biol. Lipids 2007, 1771, 255–270. [CrossRef] [PubMed]
8. Brakemeier, A.; Wullbrandt, D.; Lang, S. Microbial alkyl-sophorosides based on 1-dodecanol or 2-, 3- or
4-dodecanones. Biotechnol. Lett. 1998, 20, 215–218. [CrossRef]
Colloids Interfaces 2018, 2, 42 12 of 13
9. Van Bogaert, I.N.A.; Sabirova, J.; Develter, D.; Soetaert, W.; Vandamme, E.J. Knocking out the MFE-2 gene
of Candida bombicola leads to improved medium-chain sophorolipid production. FEMS Yeast Res. 2009, 9,
610–617. [CrossRef] [PubMed]
10. Takahashi, F.; Igarashi, K.; Hagihara, H. Identification of the fatty alcohol oxidase FAO1 from
Starmerella bombicola and improved novel glycolipids production in an FAO1 knockout mutant.
Appl. Microbiol. Biotechnol. 2016, 100, 9519–9528. [CrossRef] [PubMed]
11. Teichmann, B.; Linne, U.; Hewald, S.; Marahiel, M.A.; Bölker, M. A biosynthetic gene cluster for a secreted
cellobiose lipid with antifungal activity from Ustilago maydis. Mol. Microbiol. 2007, 66, 525–533. [CrossRef]
[PubMed]
12. Lodens, S.; De Graeve, M.; Roelants, S.L.K.W.K.W.; De Maeseneire, S.L.; Soetaert, W. Transformation of an
exotic yeast species into a platform organism: A case study for engineering glycolipid production in the
yeast Starmerella bombicola. In Synthetic Biology: Methods and Protocols; Braham, J.C., Ed.; Springer Humana
Press: New York, NY, USA, 2018; pp. 95–123. ISBN 9781493977949.
13. Lang, S.; Brakemeier, A.; Heckmann, R.; Spöckner, S.; Rau, U. Production of native and modified sophorose
lipids. Chim Oggi 2000, 18, 76–79.
14. Saerens, K.M.J.; Saey, L.; Soetaert, W. One-Step Production of Unacetylated Sophorolipids by an
Acetyltransferase Negative Candida bombicola. Biotechnol. Bioeng. 2011, 108, 2923–2931. [CrossRef] [PubMed]
15. Sambrook, J.; Russell, D. Molecular Cloning: A Laboratory Manual, 3rd ed.; Cold Spring Harbour Laboratory
Press: Cold Spring Harbor, NY, USA, 2001.
16. Gibson, D.G.; Young, L.; Chuang, R.-Y.; Venter, J.C.; Hutchison, C.A.; Smith, H.O.; Hutchison, C.A., III.;
America, N. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 2009, 6,
343–345. [CrossRef] [PubMed]
17. Asmer, H.-J.; Lang, S.; Wagner, F.; Wray, V. Microbial production, structure elucidation and bioconversion of
sophorose lipids. J. Am. Oil Chem. Soc. 1988, 65, 1460–1466. [CrossRef]
18. Petersen, B.O.; Vinogradov, E.; Kay, W.; Würtz, P.; Nyberg, N.T.; Duus, J.; Sørensen, O.W. H2BC: A new
technique for NMR analysis of complex carbohydrates. Carbohydr. Res. 2006, 341, 550–556. [CrossRef]
[PubMed]
19. Gheysen, K.; Mihai, C.; Conrath, K.; Martins, J.C. Rapid identification of common hexapyranose
monosaccharide units by a simple TOCSY matching approach. Chem. A Eur. J. 2008, 14, 8869–8878.
[CrossRef] [PubMed]
20. Kleine, M.L.; Fulco, A.J. Critical residues involved in FMN binding and catalytic activity in cytochrome
P450BM-3. J. Biol. Chem. 1993, 268, 7553–7561.
21. Cirino, P.C.C.; Arnold, F.H. Regioselectivity and Activity of Cytochrome P450 BM-3 and Mutant F87A in
Reactions Driven by Hydrogen Peroxide. Adv. Synth. Catal. 2002, 344, 932–937. [CrossRef]
22. Dietrich, M.; Do, T.A.; Schmid, R.D.; Pleiss, J.; Urlacher, V.B. Altering the regioselectivity of the subterminal
fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions. J. Biotechnol. 2009, 139, 115–117.
[CrossRef] [PubMed]
23. Davila, A.-M.; Marchal, R.; Vandecasteele, J.-P. Kinetics and balance of a fermentation free from product
inhibition: Sophorose lipid production by Candida bombicola. Appl. Microbiol. Biotechnol. 1992, 38, 6–11.
[CrossRef]
24. Van Bogaert, I.N.A.; Saerens, K.; De Muynck, C.; Develter, D.; Soetaert, W.; Vandamme, E.J.;
Van Bogaert, I.N.A.; Saerens, K.; De Muynck, C.; Develter, D.; et al. Microbial production and application of
sophorolipids. Appl. Microbiol. Biotechnol. 2007, 76, 23–34. [CrossRef] [PubMed]
25. Oliveira, M.R.; Camilios-neto, D.; Baldo, C.; Magri, A.; Celligoi, M.A.P.C. Biosynthesis and Production of
Sophorolipids. Int. J. Sci. Technol. Res. 2014, 3, 133–143.
26. Ratsep, P.; Shah, V. Identification and quantification of sophorolipid analogs using ultra-fast liquid
chromatography–mass spectrometry. J. Microbiol. Methods 2009, 78, 354–356. [CrossRef] [PubMed]
27. Guilmanov, V.; Ballistreri, A.; Impallomeni, G.; Gross, R.A.; Catania, Á.; Doria, V.A.; Chimiche, S.
Oxygen transfer rate and sophorose lipid production by Candida bombicola. Biotechnol. Bioeng. 2002, 77,
489–494. [CrossRef] [PubMed]
Colloids Interfaces 2018, 2, 42 13 of 13
28. Van Renterghem, L.; Roelants, S.L.K.W.; Baccile, N.; Uytersprot, K.; Taelman, M.C.; Everaert, B.; Mincke, S.;
Ledegen, S.; Debrouwer, S.; Scholtens, K.; et al. From lab to market: An integrated bioprocess design
approach for new-to-nature biosurfactants produced by Starmerella bombicola. Biotechnol. Bioeng. 2018, 115,
1195–1206. [CrossRef] [PubMed]
29. Roelants, S.L.K.W.; Ciesielska, K.; De Maeseneire, S.L.; Moens, H.; Everaert, B.; Verweire, S.; Denon, Q.;
Vanlerberghe, B.; Van Bogaert, I.N.A.; Van der Meeren, P.; et al. Towards the industrialization of new
biosurfactants: Biotechnological opportunities for the lactone esterase gene from Starmerella bombicola.
Biotechnol. Bioeng. 2016, 113, 550–559. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
